Encounter Frequency and Serum Glucose Level, Blood Pressure, and Cholesterol Level Control in Patients With Diabetes Mellitus

被引:91
作者
Morrison, Fritha [1 ]
Shubina, Maria [1 ]
Turchin, Alexander [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Partners HealthCare Syst, Clin Informat Res & Dev, Boston, MA USA
基金
美国医疗保健研究与质量局;
关键词
CLINICAL-PRACTICE RECOMMENDATIONS; IMPROVES GLYCEMIC CONTROL; INDIVIDUAL-RESPONSES; TREATMENT INTENSIFICATION; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; BONFERRONI PROCEDURE; PRIMARY PREVENTION; NATIONAL-HEALTH; MULTIPLE TESTS;
D O I
10.1001/archinternmed.2011.400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: More frequent patient-provider encounters may lead to faster control of hemoglobin A(1c) level, blood pressure (BP), and low-density lipoprotein (LDL) cholesterol (LDL-C) level (hereafter referred to as hemoglobin A1c, BP, and LDL-C) and improve outcomes, but no guidelines exist for how frequently patients with diabetes mellitus (DM) should be seen. Methods: This retrospective cohort study analyzed 26 496 patients with diabetes and elevated hemoglobin A(1c), BP, and/or LDL-C treated by primary care physicians at 2 teaching hospitals between January 1, 2000, and January 1, 2009. The relationship between provider encounter (defined as a note in the medical record) frequency and time to hemoglobin A(1c), BP, and LDL-C control was assessed. Results: Comparing patients who had encounters with their physicians between 1 to 2 weeks vs 3 to 6 months, median time to hemoglobin A(1c) less than 7.0% was 4.4 vs 24.9 months (not receiving insulin) and 10.1 vs 52.8 months (receiving insulin); median time to BP lower than 130/85 mm Hg was 1.3 vs 13.9 months; and median time to LDL-C less than 100 mg/dL was 5.1 vs 32.8 months, respectively (P < .001 for all). In multivariable analysis, doubling the time between physician encounters led to an increase in median time to hemoglobin A(1c) (not receiving [35%] and receiving [17%] insulin), BP (87%), and LDL-C (27%) targets (P < .001 for all). Time to control decreased progressively as encounter frequency increased up to once every 2 weeks for most targets, consistent with the pharmacodynamics of the respective medication classes. Conclusions: Primary care provider encounters every 2 weeks are associated with fastest achievement of hemoglobin A(1c), BP, and LDL-C targets for patients with diabetes mellitus.
引用
收藏
页码:1542 / 1550
页数:9
相关论文
共 62 条
[1]  
Amer Diabet Assoc, 2000, DIABETES CARE, V23, pS32
[2]  
American Diabetes Association, 2010, DIABETES CARE, V33, pS11, DOI DOI 10.2337/dc10-S011
[3]   Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes [J].
Aschner, Pablo ;
Kipnes, Mark S. ;
Lunceford, Jared K. ;
Sanchez, Matilde ;
Mickel, Carolyn ;
Williams-Herman, Debora E. .
DIABETES CARE, 2006, 29 (12) :2632-2637
[4]   Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].
BakkerArkema, RG ;
Davidson, MH ;
Goldstein, RJ ;
Davignon, J ;
Isaacsohn, JL ;
Weiss, SR ;
Keilson, LM ;
Brown, WV ;
Miller, VT ;
Shurzinske, LJ ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133
[5]   Inadequate management of blood pressure in a hypertensive population [J].
Berlowitz, DR ;
Ash, AS ;
Hickey, EC ;
Friedman, RH ;
Glickman, M ;
Kader, B ;
Moskowitz, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1957-1963
[6]   Randomised equivalence trial comparing three and six months of follow up of patients with hypertension by family practitioners [J].
Birtwhistle, RV ;
Godwin, MS ;
Delva, MD ;
Casson, RI ;
Lam, M ;
MacDonald, SE ;
Seguin, R ;
Rühland, L .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7433) :204-206B
[7]  
Blumenthal DK., 2011, GOODMAN GILMANS PHAR, V12
[8]   Primary care - Will it survive? [J].
Bodenheimer, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :861-864
[9]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[10]   Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial [J].
Chacra, A. R. ;
Tan, G. H. ;
Apanovitch, A. ;
Ravichandran, S. ;
List, J. ;
Chen, R. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (09) :1395-1406